[go: up one dir, main page]

DE69722401D1 - Kombinationen von vasopressin und adrenergischen wirkstoffen zur behandlung des plötzlichen herztods - Google Patents

Kombinationen von vasopressin und adrenergischen wirkstoffen zur behandlung des plötzlichen herztods

Info

Publication number
DE69722401D1
DE69722401D1 DE69722401T DE69722401T DE69722401D1 DE 69722401 D1 DE69722401 D1 DE 69722401D1 DE 69722401 T DE69722401 T DE 69722401T DE 69722401 T DE69722401 T DE 69722401T DE 69722401 D1 DE69722401 D1 DE 69722401D1
Authority
DE
Germany
Prior art keywords
vasopressin
combinations
active substances
pharmaceutical composition
sudden heart
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69722401T
Other languages
English (en)
Other versions
DE69722401T2 (de
Inventor
Karl Lindner
Keith G Lurie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69722401D1 publication Critical patent/DE69722401D1/de
Application granted granted Critical
Publication of DE69722401T2 publication Critical patent/DE69722401T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Saccharide Compounds (AREA)
DE69722401T 1996-03-29 1997-03-27 Kombinationen von vasopressin und adrenergischen wirkstoffen zur behandlung des plötzlichen herztods Expired - Fee Related DE69722401T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US625733 1990-12-11
US08/625,733 US5827893A (en) 1996-03-29 1996-03-29 Mechanical and pharmacological therapies to treat cardiac arrest
PCT/US1997/005056 WO1997036609A2 (en) 1996-03-29 1997-03-27 Combinations of vasopressin and adrenergic agents for the treatment of cardiac arrest

Publications (2)

Publication Number Publication Date
DE69722401D1 true DE69722401D1 (de) 2003-07-03
DE69722401T2 DE69722401T2 (de) 2004-05-06

Family

ID=24507338

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69722401T Expired - Fee Related DE69722401T2 (de) 1996-03-29 1997-03-27 Kombinationen von vasopressin und adrenergischen wirkstoffen zur behandlung des plötzlichen herztods

Country Status (9)

Country Link
US (1) US5827893A (de)
EP (1) EP0904097B1 (de)
JP (1) JP2000507954A (de)
AT (1) ATE241378T1 (de)
AU (1) AU718520B2 (de)
CA (1) CA2250420C (de)
DE (1) DE69722401T2 (de)
ES (1) ES2200171T3 (de)
WO (1) WO1997036609A2 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7195012B2 (en) * 2003-04-28 2007-03-27 Advanced Circulatory Systems, Inc. Systems and methods for reducing intracranial pressure
US7195013B2 (en) * 1993-11-09 2007-03-27 Advanced Circulatory Systems, Inc. Systems and methods for modulating autonomic function
EP1327089B1 (de) * 2000-10-18 2009-07-22 Federal-Mogul Corporation Mehraxial geschmiedeter kolben
US7682312B2 (en) * 2002-09-20 2010-03-23 Advanced Circulatory Systems, Inc. System for sensing, diagnosing and treating physiological conditions and methods
CA2506741A1 (en) * 2002-11-27 2004-06-17 Artesian Therapeutics, Inc. Compounds with mixed pde-inhibitory and .beta.-adrenergic antagonist or partial agonist activity for treatment of heart failure
JP2006513222A (ja) * 2002-12-23 2006-04-20 アルテシアン セラピューティック，インコーポレイティド アドレナリン性β受容体およびホスホジエステラーゼに対する抑制活性を有する強心性化合物
EP3064242A1 (de) 2003-04-28 2016-09-07 Advanced Circulatory Systems Inc. Lüfter und verfahren zur behandlung von kopftrauma und geringer blutzirkulation
US7836881B2 (en) * 2003-04-28 2010-11-23 Advanced Circulatory Systems, Inc. Ventilator and methods for treating head trauma and low blood circulation
US7766011B2 (en) 2003-04-28 2010-08-03 Advanced Circulatory Systems, Inc. Positive pressure systems and methods for increasing blood pressure and circulation
US8011367B2 (en) 2003-09-11 2011-09-06 Advanced Circulatory Systems, Inc. CPR devices and methods utilizing a continuous supply of respiratory gases
US8805491B2 (en) * 2004-04-20 2014-08-12 Zoll Medical Corporation Microperfusive electrical stimulation
US20080255134A1 (en) * 2004-11-30 2008-10-16 Artesian Therapeutics, Inc. Cardiotonic Compounds With Inhibitory Activity Against Beta-Adrenergic Receptors And Phosphodiesterase
JP2008521806A (ja) * 2004-11-30 2008-06-26 アーテシアン セラピューティクス， インコーポレイテッド 心不全を治療するための混合型のＰＤＥ−阻害活性およびβ−アドレナリン作用性アンタゴニスト活性または部分アゴニスト活性を有する化合物
FR2880252A1 (fr) * 2005-01-06 2006-07-07 Yves Darlas " nouvelle methode d'analyse et de mesure de la distribution ou de la reserve sanguine coronarienne "
FR2880807B1 (fr) * 2005-01-19 2007-04-13 Aguettant Sa Lab Composition pharmaceutique injectable
US8151790B2 (en) 2007-04-19 2012-04-10 Advanced Circulatory Systems, Inc. Volume exchanger valve system and method to increase circulation during CPR
US9352111B2 (en) 2007-04-19 2016-05-31 Advanced Circulatory Systems, Inc. Systems and methods to increase survival with favorable neurological function after cardiac arrest
US12016820B2 (en) 2010-02-12 2024-06-25 Zoll Medical Corporation Enhanced guided active compression decompression cardiopulmonary resuscitation systems and methods
US9724266B2 (en) 2010-02-12 2017-08-08 Zoll Medical Corporation Enhanced guided active compression decompression cardiopulmonary resuscitation systems and methods
US20140024979A1 (en) 2010-12-23 2014-01-23 Mark Bruce Radbourne Respiration-assistance systems, devices, or methods
CA2859814A1 (en) 2011-12-19 2013-06-27 ResQSystems, Inc. Systems and methods for therapeutic intrathoracic pressure regulation
US11357417B2 (en) 2012-01-19 2022-06-14 Cerebrotech Medical Systems, Inc. Continuous autoregulation system
US10743815B2 (en) 2012-01-19 2020-08-18 Cerebrotech Medical Systems, Inc. Detection and analysis of spatially varying fluid levels using magnetic signals
EP3571986A1 (de) 2012-01-19 2019-11-27 Cerebrotech Medical Systems, Inc. Diagnosesystem zur erkennung von flüssigkeitsveränderungen
US9811634B2 (en) 2013-04-25 2017-11-07 Zoll Medical Corporation Systems and methods to predict the chances of neurologically intact survival while performing CPR
US20140358047A1 (en) 2013-05-30 2014-12-04 ResQSystems, Inc. End-tidal carbon dioxide and amplitude spectral area as non-invasive markers of coronary perfusion pressure and arterial pressure
US10265495B2 (en) 2013-11-22 2019-04-23 Zoll Medical Corporation Pressure actuated valve systems and methods
US11844742B2 (en) 2014-02-19 2023-12-19 Keith G. Lurie Methods and systems to reduce brain damage
US11259988B2 (en) 2014-02-19 2022-03-01 Keith G. Lurie Active compression decompression and upper body elevation system
US10406068B2 (en) 2014-02-19 2019-09-10 Keith G. Lurie Lockable head up cardiopulmonary resuscitation support device
US10406069B2 (en) 2014-02-19 2019-09-10 Keith G. Lurie Device for elevating the head and chest for treating low blood flow states
US9801782B2 (en) 2014-02-19 2017-10-31 Keith G. Lurie Support devices for head up cardiopulmonary resuscitation
US11020314B2 (en) 2014-02-19 2021-06-01 Keith G. Lurie Methods and systems to reduce brain damage
US10245209B2 (en) 2014-02-19 2019-04-02 Keith G. Lurie Systems and methods for gravity-assisted cardiopulmonary resuscitation
US12144777B2 (en) 2014-02-19 2024-11-19 Resuscitation Innovations Llc Methods and systems to reduce brain damage
US9707152B2 (en) 2014-02-19 2017-07-18 Keith G. Lurie Systems and methods for head up cardiopulmonary resuscitation
US11096861B2 (en) 2014-02-19 2021-08-24 Keith G. Lurie Systems and methods for gravity-assisted cardiopulmonary resuscitation and defibrillation
US10667987B2 (en) 2014-02-19 2020-06-02 Keith G. Lurie Uniform chest compression CPR
US11246794B2 (en) 2014-02-19 2022-02-15 Keith G. Lurie Systems and methods for improved post-resuscitation recovery
US10350137B2 (en) 2014-02-19 2019-07-16 Keith G. Lurie Elevation timing systems and methods for head up CPR
US9750661B2 (en) 2014-02-19 2017-09-05 Keith G. Lurie Systems and methods for head up cardiopulmonary resuscitation
CA3003156C (en) * 2015-11-06 2023-12-05 Terry Vanden Hoek Peptides and method for treatment of cardiac arrest

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4693243A (en) * 1983-01-14 1987-09-15 Buras Sharon Y Conduit system for directly administering topical anaesthesia to blocked laryngeal-tracheal areas
US5588422A (en) * 1992-11-17 1996-12-31 Regents Of The University Of Minnesota Methods and pharmaceutical compositions for enhanced cardiopulmonary resuscitation

Also Published As

Publication number Publication date
AU718520B2 (en) 2000-04-13
ATE241378T1 (de) 2003-06-15
EP0904097B1 (de) 2003-05-28
AU2552797A (en) 1997-10-22
EP0904097A2 (de) 1999-03-31
WO1997036609A2 (en) 1997-10-09
DE69722401T2 (de) 2004-05-06
CA2250420C (en) 2002-12-17
US5827893A (en) 1998-10-27
JP2000507954A (ja) 2000-06-27
WO1997036609A3 (en) 1998-01-29
CA2250420A1 (en) 1997-10-09
ES2200171T3 (es) 2004-03-01

Similar Documents

Publication Publication Date Title
DE69722401D1 (de) Kombinationen von vasopressin und adrenergischen wirkstoffen zur behandlung des plötzlichen herztods
ID24901A (id) Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh
WO2001012122A3 (en) Method and system for treating cardiac arrest using hypothermia
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
DE3685853D1 (de) Mittel zur behandlung von knochenkrankheiten.
RU2039555C1 (ru) Способ лечения ожогового шока
KR930019224A (ko) 유산 위험 치료제
JP2003517020A5 (de)
RU96122561A (ru) Способ комплексной терапии заболеваний
DE69431430D1 (de) Faktor XIII zur Behandlung von Hautwunden
RU2169577C1 (ru) Капли сердечные
SU1657189A1 (ru) Способ коррекции апато-абулических состо ний при шизофрении
RU2088201C1 (ru) Способ лечения невралгии тройничного нерва
Nash Lisinopril cough
Pantridge et al. Diseases of the cardiovascular system. Management of acute myocardial infarction
RU2195947C2 (ru) Способ лечения остеохондропатий
SE9101341D0 (sv) New medicinal use
RU97110054A (ru) Способ лечения синдрома "диабетическая стопа"
RU2077892C1 (ru) Способ лечения рецидивирующего отека легких
RU95102346A (ru) Способ лечения дисциркуляторной энцефалопатии
RU2076711C1 (ru) Антиаритмический препарат
Ol'binskaia et al. The effect of the new angiotensin-converting enzyme inhibitor moexipril on the circadian rhythms of arterial pressure in hypertension patients
RU2043103C1 (ru) Средство, уменьшающее внешнесекреторную недостаточность поджелудочной железы при хроническом панкреатите
RU94000001A (ru) Средство для нормализации половой потенции мужчин
Hudak et al. Evaluation and mechanisms of action of several experimental hypotensive agents

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee